IRIS Accounts Production v24.3.2.46 12557227 Board of Directors 1.5.23 30.4.24 30.4.24 0 0 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh125572272023-04-30125572272024-04-30125572272023-05-012024-04-30125572272022-04-30125572272022-05-012023-04-30125572272023-04-3012557227ns15:EnglandWales2023-05-012024-04-3012557227ns14:PoundSterling2023-05-012024-04-3012557227ns10:Director12023-05-012024-04-3012557227ns10:PrivateLimitedCompanyLtd2023-05-012024-04-3012557227ns10:SmallEntities2023-05-012024-04-3012557227ns10:AuditExempt-NoAccountantsReport2023-05-012024-04-3012557227ns10:SmallCompaniesRegimeForDirectorsReport2023-05-012024-04-3012557227ns10:SmallCompaniesRegimeForAccounts2023-05-012024-04-3012557227ns10:FullAccounts2023-05-012024-04-3012557227ns10:Director22023-05-012024-04-3012557227ns10:Director32023-05-012024-04-3012557227ns10:RegisteredOffice2023-05-012024-04-3012557227ns5:CurrentFinancialInstruments2024-04-3012557227ns5:CurrentFinancialInstruments2023-04-3012557227ns5:ShareCapital2024-04-3012557227ns5:ShareCapital2023-04-3012557227ns5:RetainedEarningsAccumulatedLosses2024-04-3012557227ns5:RetainedEarningsAccumulatedLosses2023-04-3012557227ns5:WithinOneYearns5:CurrentFinancialInstruments2024-04-3012557227ns5:WithinOneYearns5:CurrentFinancialInstruments2023-04-30
REGISTERED NUMBER: 12557227 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 APRIL 2024

FOR

AIDA ONCOLOGY LIMITED

AIDA ONCOLOGY LIMITED (REGISTERED NUMBER: 12557227)

CONTENTS OF THE FINANCIAL STATEMENTS
For The Year Ended 30 April 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


AIDA ONCOLOGY LIMITED

COMPANY INFORMATION
For The Year Ended 30 April 2024







DIRECTORS: P Buhl Jensen
A Gardiner
N Goldsmith





REGISTERED OFFICE: London Bioscience Innovation Centre
2 Royal College Street
London
NW1 0NH





REGISTERED NUMBER: 12557227 (England and Wales)





ACCOUNTANTS: Redfin Management Limited
111 Charterhouse Street
Farringdon
London
EC1M 6AW

AIDA ONCOLOGY LIMITED (REGISTERED NUMBER: 12557227)

BALANCE SHEET
30 April 2024

2024 2023
Notes £    £   
CURRENT ASSETS
Debtors 4 5,683 5,511
Cash in hand 17,656 21,536
23,339 27,047
CREDITORS
Amounts falling due within one year 5 32,611 35,018
NET CURRENT LIABILITIES (9,272 ) (7,971 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(9,272

)

(7,971

)

CAPITAL AND RESERVES
Called up share capital 1,000 1,000
Retained earnings (10,272 ) (8,971 )
(9,272 ) (7,971 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 23 January 2025 and were signed on its behalf by:





A Gardiner - Director


AIDA ONCOLOGY LIMITED (REGISTERED NUMBER: 12557227)

NOTES TO THE FINANCIAL STATEMENTS
For The Year Ended 30 April 2024


1. STATUTORY INFORMATION

Aida Oncology Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Grants
Grants are accounted for using the accrual model and recognised in income on a systematic basis over the period in which the related costs, for which the grant is intended to compensate, are recognised.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Other debtors 5,683 5,511

AIDA ONCOLOGY LIMITED (REGISTERED NUMBER: 12557227)

NOTES TO THE FINANCIAL STATEMENTS - continued
For The Year Ended 30 April 2024


5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors (1 ) 216
Taxation and social security - 255
Other creditors 32,612 34,547
32,611 35,018

6. RELATED PARTY DISCLOSURES

Included in other creditors are amounts owed to related companies totalling £14,900 (2023: £14,900). Debtors includes amount of £5,512 (2023: £5,512) owed by related companies.

These amounts are interest free and repayable on demand.